Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E O Dillingham

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1995
Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomidesD Herron, E O Dillingham, B A Lyman, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1988
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro activity and toxicityW H Lawrence, P A Tisdelle, J E Turner, et al.
Medical Progress Through Technology|January 1, 1986
Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experimentsA Lasslo, E O Dillingham, J C McCastlain, et al.
Journal of Medicinal Chemistry|January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitorsX Zheng, S R Salgia, W B Thompson, et al.
Journal of Medicinal Chemistry|August 7, 1992
Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesZ Feng, R Gollamudi, E O Dillingham, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1995
Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomidesD Herron, E O Dillingham, B A Lyman, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1988
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro activity and toxicityW H Lawrence, P A Tisdelle, J E Turner, et al.
Medical Progress Through Technology|January 1, 1986
Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experimentsA Lasslo, E O Dillingham, J C McCastlain, et al.
Journal of Medicinal Chemistry|January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitorsX Zheng, S R Salgia, W B Thompson, et al.
Journal of Medicinal Chemistry|August 7, 1992
Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesZ Feng, R Gollamudi, E O Dillingham, et al.
Pageof 3